🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Patricia Ho

Columbia University Irving Medical Center

ORCID: 0000-0002-4622-8188

Also affiliated with Columbia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
6.6Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A molecular single-cell lung atlas of lethal COVID-19

Nature(2021)10.1038/s41586-021-03569-1
Top 4%
5.3DataRank
Top 4%737 citations

Jana Biermann, Huachao Huang, Yiping Wang, Ajay Nair, Somnath Tagore +39 more

Papers

Driven by 15 papers — median percentile 90. Top paper: “Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion”.

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion

Nature Genetics(2021)10.1038/s41588-021-00779-1
N/A
6.5DataRank · unranked
271 citations

Johannes C. Melms, Pratiksha I. Thakore, Kathryn Geiger-Schuller, Patricia Ho, Adrienne Luoma +17 more

A molecular single-cell lung atlas of lethal COVID-19

Nature(2021)10.1038/s41586-021-03569-1
Top 4%
5.3DataRank
Top 4%737 citations

Jana Biermann, Huachao Huang, Yiping Wang, Ajay Nair, Somnath Tagore +39 more

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Cancer Cell(2023)10.1016/j.ccell.2023.05.014
N/A
1.8DataRank · unranked
96 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah +28 more

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9
Top 16%
1.3DataRank
Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

Structural variants shape driver combinations and outcomes in pediatric high-grade glioma

Nature Cancer(2022)10.1038/s43018-022-00403-z
N/A
1.1DataRank · unranked
48 citations

Ofer Shapira, Noah F. Greenwald, Travis Zack, Jeremiah A. Wala, Jessica W. Tsai +35 more

CloneSifter: enrichment of rare clones from heterogeneous cell populations

BMC Biology(2020)10.1186/s12915-020-00911-3
N/A
0.944DataRank · unranked
26 citations

FuNien Tsai, Anthony J. Garrity, Ryan O’Rourke, Lisa Brenan, Patricia Ho +7 more

Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens

Nature Biotechnology(2024)10.1038/s41587-024-02235-x
N/A
0.896DataRank · unranked
36 citations

Parin Shah, Neeharika Kothapalli, Shivem B. Shah, Gergő Nikolényi, D. Zack Brodtman +12 more

Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation

Nature Cancer(2024)10.1038/s43018-023-00704-x
N/A
0.464DataRank · unranked
21 citations

Tyler J. Aprati, Wei-Yu Chi, Johannes C. Melms, Clemens Hug, Stephanie H. Davis +40 more

Multi-modal pooled Perturb-CITE-Seq screens in patient models define novel mechanisms of cancer immune evasion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.01.267211
N/A
0.375DataRank · unranked
5 citations

Johannes C. Melms, Pratiksha I. Thakore, Kathryn R. Geiger-Schuller, Patricia Ho, Adrienne Luoma +15 more

Large-scale CRISPR-Cas9 screens to define regulators of immune checkpoints

Methods in cell biology(2025)10.1016/bs.mcb.2025.10.011
N/A
0DataRank · unranked
1 citations

Johannes C. Melms, Patricia Ho, Benjamin Izar, Michael Mu

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell(2022)10.1016/j.cell.2022.06.007
N/A
0DataRank · unranked
216 citations

Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz +54 more

The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485049
N/A
0DataRank · unranked
10 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Shivem B. Shah, Zachary Walsh +21 more

Multi-modal single-cell and whole-genome sequencing of minute, frozen specimens to propel clinical applications

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.13.480272
N/A
0DataRank · unranked
3 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Patricia Ho +15 more

SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion

Cell(2024)10.1016/j.cell.2024.01.008
N/A
0DataRank · unranked
95 citations

Alessandro Vasciaveo, Angelo Taglialatela, Xiao Chen, Tessa M. Firestone, Allison R. Hickman +28 more

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

Nature Communications(2024)10.1038/s41467-023-44575-3
N/A
0DataRank · unranked
0 citations

Zachary Walsh, Johannes C. Melms, Jeffery L. Port, Benjamin E. Lee, Abu Nasar +17 more